Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Nature Reviews. Nephrology
|
February 24, 2010
Recent advances in renal phosphate handling
Emily G Farrow, Kenneth E White
Expert Review of Endocrinology & Metabolism
|
March 16, 2010
Tumor-induced osteomalacia
Emily G Farrow, Kenneth E White
Best Practice & Research. Clinical Rheumatology
|
December 7, 2011
Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho)
Emily G Farrow, Erik A Imel, Kenneth E White
Personalized Medicine
|
November 23, 2012
Genomic medicine: evolving science, evolving ethics
Sarah E Soden, Emily G Farrow, Carol J Saunders, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2009
Initial FGF23-mediated signaling occurs in the distal convoluted tubule
Emily G Farrow, Siobhan I Davis, Lelia J Summers, et al.
Clinical Chemistry
|
April 2, 2024
More Than a Decade of Rapid Genomic Sequencing: Where Are We Now?
Carol J Saunders, Luca Brunelli, Michael J Deem, et al.
Pharmacogenomics
|
March 15, 2017
In vivo characterization of CYP2D6*12, *29 and *84 using dextromethorphan as a probe drug: a case report
Andrea Gaedigk, Greyson P Twist, Emily G Farrow, et al.
The Journal of Endocrinology
|
August 3, 2010
Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation
Emily G Farrow, Lelia J Summers, Susan C Schiavi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2008
Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia
Whitney W Brown, Harald Jüppner, Craig B Langman, et al.
American Journal of Medical Genetics. Part A
|
February 14, 2006
Extended mutational analyses of FGFR1 in osteoglophonic dysplasia
Emily G Farrow, Siobhan I Davis, Sean D Mooney, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Nature Reviews. Nephrology
|
February 24, 2010
Recent advances in renal phosphate handling
Emily G Farrow, Kenneth E White
Expert Review of Endocrinology & Metabolism
|
March 16, 2010
Tumor-induced osteomalacia
Emily G Farrow, Kenneth E White
Best Practice & Research. Clinical Rheumatology
|
December 7, 2011
Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho)
Emily G Farrow, Erik A Imel, Kenneth E White
Personalized Medicine
|
November 23, 2012
Genomic medicine: evolving science, evolving ethics
Sarah E Soden, Emily G Farrow, Carol J Saunders, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2009
Initial FGF23-mediated signaling occurs in the distal convoluted tubule
Emily G Farrow, Siobhan I Davis, Lelia J Summers, et al.
Clinical Chemistry
|
April 2, 2024
More Than a Decade of Rapid Genomic Sequencing: Where Are We Now?
Carol J Saunders, Luca Brunelli, Michael J Deem, et al.
Pharmacogenomics
|
March 15, 2017
In vivo characterization of CYP2D6*12, *29 and *84 using dextromethorphan as a probe drug: a case report
Andrea Gaedigk, Greyson P Twist, Emily G Farrow, et al.
The Journal of Endocrinology
|
August 3, 2010
Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation
Emily G Farrow, Lelia J Summers, Susan C Schiavi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 16, 2008
Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia
Whitney W Brown, Harald Jüppner, Craig B Langman, et al.
American Journal of Medical Genetics. Part A
|
February 14, 2006
Extended mutational analyses of FGFR1 in osteoglophonic dysplasia
Emily G Farrow, Siobhan I Davis, Sean D Mooney, et al.
Page
of 6